BIO-TECHNE Corp (TECH) stock
TECHNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q/A on Nov 12, 2026Score 12/3051% above fair value
$72.63−0.16 (-0.22%)
Close on Nov 17, 2026Market cap $11.41BP/E 62.6Yield 0.44%
Bio-Techne gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Bio-Techne's gross profit for the twelve months ending Jun 30, 2026 was $799.07M, up 1.1% year over year. For fiscal 2026 it was $799.07M, up 1.1% from the year before. Over ten years it grew 9.0% a year on average. The highest annual figure on record is $799.07M in fiscal 2026.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $799.07M | +1.1% |
| FY2025 | Jun 30, 2025 | $790.27M | +2.7% |
| FY2024 | Jun 30, 2024 | $769.73M | -0.0% |
| FY2023 | Jun 30, 2023 | $769.82M | +1.8% |
| FY2022 | Jun 30, 2022 | $756.50M | +19.5% |
| FY2021 | Jun 30, 2021 | $632.85M | +31.0% |
| FY2020 | Jun 30, 2020 | $483.19M | +2.0% |
| FY2019 | Jun 30, 2019 | $473.49M | +9.6% |
| FY2018 | Jun 30, 2018 | $432.14M | +15.4% |
| FY2017 | Jun 30, 2017 | $374.54M | +11.3% |
| FY2016 | Jun 30, 2016 | $336.66M | +9.6% |
| FY2015 | Jun 30, 2015 | $307.28M | +22.2% |
| FY2014 | Jun 30, 2014 | $251.41M | +8.8% |
| FY2013 | Jun 30, 2013 | $231.11M | -2.0% |
| FY2012 | Jun 30, 2012 | $235.80M | +4.8% |
| FY2011 | Jun 30, 2011 | $224.94M | +5.0% |
| FY2010 | Jun 30, 2010 | $214.15M | +2.9% |
| FY2009 | Jun 30, 2009 | $208.03M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $211.39M | +6.3% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $208.29M | -2.9% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $191.28M | -1.3% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $188.11M | +2.8% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $198.81M | -2.2% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $214.56M | +4.9% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $193.89M | +9.8% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $183.02M | -1.2% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $203.35M | -0.7% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $204.60M | +1.2% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $176.59M | -3.7% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $185.19M | +3.1% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $204.70M | +2.2% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $202.16M | +0.3% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $183.36M | -0.2% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $179.60M | +5.0% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $200.35M | +13.9% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $201.46M | +19.7% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $183.69M | +21.7% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $171.00M | +24.2% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $175.94M | +55.3% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $168.27M | +29.4% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $150.90M | +24.3% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $137.73M | +16.3% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $113.31M | -11.7% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $130.06M | +4.4% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $121.40M | +7.4% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $118.41M | +10.0% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $128.26M | +5.0% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $124.61M | +13.0% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $113.02M | +11.0% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $107.60M | +9.9% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $122.18M | +19.4% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $110.26M | +14.0% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $101.83M | +15.5% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $97.87M | +12.0% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $102.37M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $96.68M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $88.14M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $87.35M | – |
See a number that looks wrong?